107 related articles for article (PubMed ID: 24797787)
1. Development of hepatitis C virus genotype 3a cell culture system.
Kim S; Date T; Yokokawa H; Kono T; Aizaki H; Maurel P; Gondeau C; Wakita T
Hepatology; 2014 Dec; 60(6):1838-50. PubMed ID: 24797787
[TBL] [Abstract][Full Text] [Related]
2. Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a/2a (S52/JFH1) viruses.
Gottwein JM; Scheel TK; Hoegh AM; Lademann JB; Eugen-Olsen J; Lisby G; Bukh J
Gastroenterology; 2007 Nov; 133(5):1614-26. PubMed ID: 17983807
[TBL] [Abstract][Full Text] [Related]
3. In vitro efficacy of approved and experimental antivirals against novel genotype 3 hepatitis C virus subgenomic replicons.
Yu M; Corsa AC; Xu S; Peng B; Gong R; Lee YJ; Chan K; Mo H; Delaney W; Cheng G
Antiviral Res; 2013 Nov; 100(2):439-45. PubMed ID: 24013001
[TBL] [Abstract][Full Text] [Related]
4. Cell culture and infection system for hepatitis C virus.
Kato T; Date T; Murayama A; Morikawa K; Akazawa D; Wakita T
Nat Protoc; 2006; 1(5):2334-9. PubMed ID: 17406476
[TBL] [Abstract][Full Text] [Related]
5. Morphological changes in intracellular lipid droplets induced by different hepatitis C virus genotype core sequences and relationship with steatosis.
Piodi A; Chouteau P; Lerat H; Hézode C; Pawlotsky JM
Hepatology; 2008 Jul; 48(1):16-27. PubMed ID: 18570290
[TBL] [Abstract][Full Text] [Related]
6. SUMO1 depletion prevents lipid droplet accumulation and HCV replication.
Akil A; Wedeh G; Zahid Mustafa M; Gassama-Diagne A
Arch Virol; 2016 Jan; 161(1):141-8. PubMed ID: 26449956
[TBL] [Abstract][Full Text] [Related]
7. Replication and infectivity of a novel genotype 1b hepatitis C virus clone.
Date T; Morikawa K; Tanaka Y; Tanaka-Kaneko K; Sata T; Mizokami M; Wakita T
Microbiol Immunol; 2012 May; 56(5):308-17. PubMed ID: 22320232
[TBL] [Abstract][Full Text] [Related]
8. Replication of hepatitis C virus genotype 3a in cultured cells.
Saeed M; Gondeau C; Hmwe S; Yokokawa H; Date T; Suzuki T; Kato T; Maurel P; Wakita T
Gastroenterology; 2013 Jan; 144(1):56-58.e7. PubMed ID: 22999961
[TBL] [Abstract][Full Text] [Related]
9. [Production of infectious hepatitis C virus in cell culture].
Kato T; Wakita T
Uirusu; 2005 Dec; 55(2):287-95. PubMed ID: 16557015
[TBL] [Abstract][Full Text] [Related]
10. An in vitro model of hepatitis C virus genotype 3a-associated triglycerides accumulation.
Abid K; Pazienza V; de Gottardi A; Rubbia-Brandt L; Conne B; Pugnale P; Rossi C; Mangia A; Negro F
J Hepatol; 2005 May; 42(5):744-51. PubMed ID: 15826725
[TBL] [Abstract][Full Text] [Related]
11. Lipid Droplets Accumulation during Hepatitis C Virus Infection in Cell-Culture Varies among Genotype 1-3 Strains and Does Not Correlate with Virus Replication.
Galli A; Ramirez S; Bukh J
Viruses; 2021 Feb; 13(3):. PubMed ID: 33671086
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of fatty acid synthase promoter by hepatitis C virus core protein: genotype-3a core has a stronger effect than genotype-1b core.
Jackel-Cram C; Babiuk LA; Liu Q
J Hepatol; 2007 Jun; 46(6):999-1008. PubMed ID: 17188392
[TBL] [Abstract][Full Text] [Related]
13. Cutting the gordian knot-development and biological relevance of hepatitis C virus cell culture systems.
Gottwein JM; Bukh J
Adv Virus Res; 2008; 71():51-133. PubMed ID: 18585527
[TBL] [Abstract][Full Text] [Related]
14. Production of infectious chimeric hepatitis C virus genotype 2b harboring minimal regions of JFH-1.
Murayama A; Kato T; Akazawa D; Sugiyama N; Date T; Masaki T; Nakamoto S; Tanaka Y; Mizokami M; Yokosuka O; Nomoto A; Wakita T
J Virol; 2012 Feb; 86(4):2143-52. PubMed ID: 22156532
[TBL] [Abstract][Full Text] [Related]
15. Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs.
Gottwein JM; Scheel TK; Jensen TB; Lademann JB; Prentoe JC; Knudsen ML; Hoegh AM; Bukh J
Hepatology; 2009 Feb; 49(2):364-77. PubMed ID: 19148942
[TBL] [Abstract][Full Text] [Related]
16. HCV 3a core protein increases lipid droplet cholesteryl ester content via a mechanism dependent on sphingolipid biosynthesis.
Loizides-Mangold U; Clément S; Alfonso-Garcia A; Branche E; Conzelmann S; Parisot C; Potma EO; Riezman H; Negro F
PLoS One; 2014; 9(12):e115309. PubMed ID: 25522003
[TBL] [Abstract][Full Text] [Related]
17. Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization.
Scheel TK; Gottwein JM; Jensen TB; Prentoe JC; Hoegh AM; Alter HJ; Eugen-Olsen J; Bukh J
Proc Natl Acad Sci U S A; 2008 Jan; 105(3):997-1002. PubMed ID: 18195353
[TBL] [Abstract][Full Text] [Related]
18. Establishment of Replication-Competent HCV Strain with Minimum Modifications.
Kato T; Murayama A; Wakita T
Methods Mol Biol; 2019; 1911():73-83. PubMed ID: 30593618
[TBL] [Abstract][Full Text] [Related]
19. An overview: in vitro models of HCV replication in different cell cultures.
Tariq H; Manzoor S; Parvaiz F; Javed F; Fatima K; Qadri I
Infect Genet Evol; 2012 Jan; 12(1):13-20. PubMed ID: 22061839
[TBL] [Abstract][Full Text] [Related]
20. Arylacetamide deacetylase: a novel host factor with important roles in the lipolysis of cellular triacylglycerol stores, VLDL assembly and HCV production.
Nourbakhsh M; Douglas DN; Pu CH; Lewis JT; Kawahara T; Lisboa LF; Wei E; Asthana S; Quiroga AD; Law LM; Chen C; Addison WR; Nelson R; Houghton M; Lehner R; Kneteman NM
J Hepatol; 2013 Aug; 59(2):336-43. PubMed ID: 23542347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
